Aptose Biosciences Inc’s recent filing unveils that its Chair, President & CEO Rice William G. acquired Company’s shares for reported $20000.0 on Nov 25 ’24. In the deal valued at $0.20 per share,100,000 shares were bought. As a result of this transaction, Rice William G. now holds 613,252 shares worth roughly $0.12 million.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Cantor Fitzgerald initiated its Aptose Biosciences Inc [APTO] rating to an Overweight in a research note published on October 19, 2020; the price target was $10. A number of analysts have revised their coverage, including Alliance Global Partners’s analysts, who began to cover the stock in late September with a ‘”a Buy”‘ rating. Maxim Group began covering APTO with “Buy” recommendation on February 20, 2020. H.C. Wainwright maintained its rating on February 06, 2020. It rated APTO as “a Buy”.
Price Performance Review of APTO
On Tuesday, Aptose Biosciences Inc [NASDAQ:APTO] saw its stock fall -0.85% to $0.19. Over the last five days, the stock has lost -0.90%. Aptose Biosciences Inc shares have fallen nearly -92.61% since the year began. Nevertheless, the stocks have fallen -92.15% over the past one year. While a 52-week high of $2.68 was reached on 01/09/24, a 52-week low of $0.13 was recorded on 11/22/24. SMA at 50 days reached $0.3087, while 200 days put it at $0.7460.
Levels Of Support And Resistance For APTO Stock
The 24-hour chart illustrates a support level at 0.1794, which if violated will result in even more drops to 0.1712. On the upside, there is a resistance level at 0.1964. A further resistance level may holdings at 0.2052. The Relative Strength Index (RSI) on the 14-day chart is 28.74, which indicates oversold technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.0009, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 66.29%. Stochastics %K at 43.84% indicates the stock is a holding.
How much short interest is there in Aptose Biosciences Inc?
A steep rise in short interest was recorded in Aptose Biosciences Inc stocks on 2024-11-29, dropping by 21448.0 shares to a total of 0.1 million shares. Yahoo Finance data shows the prior-month short interest on 2024-10-31 was 0.12 million shares. There was a decline of -21.07%, which implies that there is a negative sentiment for the stock.
The most recent change occurred on January 09, 2020 when Piper Sandler began covering the stock and recommended ‘”an Overweight”‘ rating along with a $10 price target.
